Literature DB >> 15638833

The use of allelic expression differences to ascertain functional polymorphisms acting in cis: analysis of MMP1 transcripts in normal lung tissue.

J Heighway1, N L Bowers, S Smith, D C Betticher, M F Santibáñez Koref.   

Abstract

Summary Aberrant expression of matrix metalloproteinase 1 (MMP1) has been implicated in a number of pathological conditions of the lung. In vitro results and analysis of tumours and cell lines suggest that an insertion/deletion polymorphism at position -1607 in the promoter of the gene can influence expression levels. However, whether this polymorphism is associated with differences in expression in normal lung tissue remains to be established. Polymorphisms affecting expression in cis will lead to alleles with different expression levels and will result in unequal expression of both alleles in heterozygous individuals (allelic expression imbalance, AEI). This can be detected using a transcribed marker. Here we follow a new approach and use AEI to ascertain that the -1607 polymorphism is associated with allelic expression differences of MMP1 in normal lung tissue. This approach could be used to map the sites associated with inter-individual expression differences in other genes. This is of particular interest since such sites allow prediction of expression levels, and can be used to test whether genetically determined differences in expression influence inter-individual differences of a phenotype of interest, such as disease predisposition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638833     DOI: 10.1046/j.1529-8817.2004.00135.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  7 in total

1.  An expectation-maximization algorithm for the analysis of allelic expression imbalance.

Authors:  M D Teare; J Heighway; M F Santibáñez Koref
Journal:  Am J Hum Genet       Date:  2006-06-30       Impact factor: 11.025

2.  Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15.

Authors:  Chang Sun; Catherine Southard; David B Witonsky; Olufunmilayo I Olopade; Anna Di Rienzo
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

3.  Association between matrix metalloproteinase 1 -1607 1G>2G polymorphism and cancer risk: a meta-analysis including 19706 subjects.

Authors:  Guoda Han; Zhijiang Wei; Zhiliang Lu; Haibin Cui; Xiyong Bai; Huai'e Ge; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

4.  Comparing methods for mapping cis acting polymorphisms using allelic expression ratios.

Authors:  Marion Dawn Teare; Suteeraporn Pinyakorn; James Heighway; Mauro F Santibanez Koref
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

5.  Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells.

Authors:  Lili Milani; Manu Gupta; Malin Andersen; Sumeer Dhar; Mårten Fryknäs; Anders Isaksson; Rolf Larsson; Ann-Christine Syvänen
Journal:  Nucleic Acids Res       Date:  2007-01-31       Impact factor: 16.971

6.  Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.

Authors:  Christopher Ricketts; Maurice P Zeegers; Jan Lubinski; Eamonn R Maher
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

7.  STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression.

Authors:  Michael S Cunnington; Chris Kay; Peter J Avery; Bongani M Mayosi; Mauro Santibanez Koref; Bernard Keavney
Journal:  BMC Med Genet       Date:  2009-12-14       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.